Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07676461 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy

Study acronym: ATLAS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Collaborators: 2 to 1v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective observational cohort study conducted at Fundación CTIC in Bogotá, Colombia. It characterizes the oral, fecal and intratumoral microbiome of Colombian adults with advanced solid tumors (gastric, colorectal, breast, cervical and head-and-neck cancer) who receive first-line immunotherapy as standard of care, and compares them with healthy volunteers. Using multi-omics (HiFi metagenomics, 16S, tumor RNA-Seq and untargeted metabolomics), the study aims to identify microbial signatures associated with treatment response and survival, building the initial Colombian cohort of a Cancer Microbiome Atlas with Latin American projection.
Trial Details
NCT Number NCT07676461
Lead Sponsor Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Collaborators: American Society of Clinical Oncology
Conditions
(from sponsor)		 Gastric Cancer, Colorectal Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer (H&N)
Related terms Breast Neoplasms, Colorectal Neoplasms, Head and Neck Neoplasms, Neoplasms, Stomach Neoplasms, Uterine Cervical Neoplasms
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov